Navigation Links
Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
Date:12/10/2009

siness unit provides both diversification and growth potential to the company's operations. Elanco is currently the sixth largest animal health company in the industry and its sales continue to grow at a rate faster than the overall animal health market, bolstered by recent acquisitions and the launch of its companion animal business. Year-to-date 2009 animal health sales exceeded $850.0 million.

Elanco maintains the top position in the medicated feed additives and dairy segments and also ranks first in research and development output in the U.S., delivering more new molecules over the past six years than any other company in its industry. In the companion animal segment, Elanco is growing faster than the competition, driven by the growth of Comfortis®. In 2010, Elanco is planning for 7 new product launches and expanded indications, including two new companion animal products.

Elanco is positioned to double revenue in five years with five strategic initiatives:

  1. Increased investment and industry leadership in innovation;
  2. Continued growth and increased presence in the companion animal business,
  3. Greater investment and focus on emerging market opportunities;
  4. Transforming its manufacturing cost structure to better support innovation growth and emerging market opportunities; and
  5. A further-enhanced business unit model to amplify "best in industry" employee engagement and focused execution.

With strategic investments in research and development, along with focused efforts to accelerate growth in key emerging markets and the companion animal segment, Elanco is positioned to deliver double-digit annual income growth over the next five years.

2009 Financial Guidance

The company confirmed its current financial guidance for 2009. The company expects its full-year 2009 earnings per share to be in the range of $3.90 to $4.00 on a reported basis, or $4.30 to $4
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Investor-Edge has initiated coverage on the following equities: ... (NASDAQ: HZNP ), Endocyte Inc. (NASDAQ: ... and Theravance Inc. (NASDAQ: THRX ). Free research ... . On Tuesday, November 25, 2014, the NASDAQ ... Average edged 0.02% lower, to finish the day at 17,814.94, ...
(Date:11/26/2014)... RADNOR, Pa. , Nov. 26, 2014 ... dedicated to the development of innovative transdermal synthetic cannabinoid ... the Piper Jaffray 26th Annual Healthcare Conference 2014. The ... the New York Palace in New York ... , will present at 4:50 pm on Tuesday, December ...
(Date:11/26/2014)... NEW YORK and ... the leading distributor of market intelligence, MarketResearch.com is pleased ... by IQ4I Research and Consultancy focusing on the active ... about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Ingredients Global Market – Forecast to 2020 ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3
... Oct. 6 BioTrends Research Group, Inc. recently published ... This report is ... practice in China and qualitative interviews conducted with ten ... of nephrology practice in China and focuses specifically on ...
... (Nasdaq: ARAY ), a global leader in ... patient has been treated with the CyberKnife ® ... the treatment of both cancerous and non-cancerous tumors anywhere ... CyberKnife radiosurgery received treatment during Accuray,s fiscal 2010, which ...
Cached Medicine Technology:New Report by BioTrends Examines the Treatment of Renal Anemia in China 2100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System 2100,000th Patient Treated With Accuray's CyberKnife® Robotic Radiosurgery System 3
(Date:11/27/2014)... New York, New York (PRWEB) November 27, 2014 ... http://www.risperdallawsuit2014.com/ ) have been filed in a ... Bernstein Liebhard LLP reports. , Documents recently ... show 1,079 records included in the state proceeding, ... treat schizophrenia, bipolar disorder and other psychiatric conditions. ...
(Date:11/27/2014)... -- Thanksgiving meals can pose a challenge for people ... says. Many traditional Thanksgiving dishes -- such as ... gluten-free, but "when it comes to pies, stuffing, gravy, ... Anca Safta, director of the Gluten and Allergic Digestive ... North Carolina, said in a center news release. ...
(Date:11/27/2014)... Vegas, NV (PRWEB) November 27, 2014 ... 2014 shopping season has officially launched, Emassagechair.com ... and Cyber Monday Discount Event. , Negotiating on ... relationships with top massage chair brands, Emassagechair.com has generated ... their best deals and biggest discounts yet. , Shoppers ...
(Date:11/27/2014)... 27, 2014 “Wekho” was featured on NewsWatch ... and coolest mobile applications on the iOS, Android, and Windows ... NewsWatch, conducted the app review and shared with ... people. , An interesting new way to travel and experience ... devices. It’s called Wekho and it’s a free geolocation ...
(Date:11/27/2014)... This is a professional and ... For an overview analysis, the report introduces Insulin ... structure, industry overview, policy analysis, and news analysis, ... covers information on policy, plans for Insulin Market ... much more. , This report also ...
Breaking Medicine News(10 mins):Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 2Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 3Health News:New Risperdal Lawsuits Added to Philadelphia Litigation, Bernstein Liebhard LLP Reports 4Health News:Expert Shares Gluten-Free Thanksgiving Tips 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... Mich., Oct. 17 The State Senate,Committee passed legislation today ... on Michigan roads. In their,latest bid to rid riders of ... solution. For a $100 fee, motorcyclists,can buy their way out ... voted on by the State Senate in the near,future. The ...
... to change cervical cancer screening practices, , , WEDNESDAY, Oct. 17 ... -- which causes most cervical cancers -- was far better ... studies show. , What,s unclear, however, is whether or not ... because it can have a slightly higher false positive rate, ...
... for research into treatment, cure for,devastating lung disease, ... Fibrosis (CPF) announced the passage of important legislation,that ... of idiopathic,pulmonary fibrosis (IPF), a deadly lung disease ... and a diseases which claims 40,000 lives a,year, ...
... SAN FRANCISCO, Oct. 17 Collaborative Drug Discovery,Inc. ... six years of,recent publications focused on the fight ... data are available to researchers free of charge, ... of Medicinal Chemistry, Bioorganic &,Medicinal Chemistry, the Journal ...
... Have Their Dreams Come True ... LAS VEGAS, Oct. 17 The Emerald Dream Team, headed ... National Search,for 12 women who have been diagnosed with breast cancer ... whisked away, with a,guest, to Las Vegas on Dec. 26th, all ...
... and CEDAR KNOLLS, N.J., Oct. 17 ,PainCare ... of the nation,s leading providers,of pain-focused medical ... Inc. (OTC Bulletin Board: MDFI), a company ... today jointly,announced the formation of a partnership ...
Cached Medicine News:Health News:Michigan Senate Committee Votes in Favor of 'Opt-Out' Option for State's Helmet Law; AAA Says Deaths and Injuries Will Increase 2Health News:HPV Test Bests Pap Smear in Studies 2Health News:HPV Test Bests Pap Smear in Studies 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 2Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 3Health News:Resolution Recognizing Pulmonary Fibrosis Challenges Overwhelmingly Passes House 4Health News:Free Access to Literature Data on Chagas' Disease Offered Online: Collaborative Drug Discovery, Inc. provides Neglected Disease researchers with 'archive mine and collaborate' access to small molecule bioactivity SAR data on parasitic disease 2Health News:The Emerald Dream Ball 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 2Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 3Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 4Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 5Health News:PainCare Holdings and MedeFile International Form Partnership to Market Personal Electronic Medical Records Direct to Consumers 6
Full automatic, ready-to-use strip washer....
The Wellwash 4 Mk 2 combines high performance and flexibility with reliability, simplicity and ease of use....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
... an unmatched combination of speed, accuracy and ... assessing and monitoring a patient's A1C levels., ... simple fingerstick and delivers A1C results in ... a proven and time-tested having received full ...
Medicine Products: